Skip navigation

Vaccine Production:

Potential Engineering Approaches to a Pandemic

Home :: Speakers :: William L. Warren

Conference Speaker

William L. Warren, Ph.D.
CEO, VaxDesign Corp

Dr. Warren is CEO of VaxDesign Corporation and Managing Partner of Sciperio Inc. that specialize in bio-technologies related to tissue engineering of immunological tissue constructs, microparticle-based innate and adaptive immunotherapy treatments (VaxDesign), rare event cellular imaging processes, digital printing deposition technologies, RF wireless communications, and water purification technologies (Sciperio).

From 1997 to 2001, Dr. Warren directed a diverse portfolio of over $125M of R&D programs at the Defense Advanced Research Projects Agency. In this capacity, Dr. Warren led interdisciplinary teams of more than 200 academic, government, and industrial participants. His programs were successful in the creation of several revolutionary technologies and, most importantly, in their follow-on transition to multiple commercial and military products through private capitalization activities and follow-on acquisition programs. Prior to that, he was a principal member of the technical staff in the materials directorate at Sandia National Laboratories from 1990 to 1997. He received his B.Sc. Honors and Ph.D. degrees in Engineering Science from The Pennsylvania State University in 1986 and 1990, respectively.

He is the author of over 180 publications, the editor of three conference proceedings, has over 170 scientific presentations and has 15 patents issued, several pending patents and provisional patents on vaccines, tissue engineering, and solid state electronics, and water purification.

Dr. Warren has received numerous awards, including the R&D 100 award in 2003 and 1997, the 2004 Frost and Sullivan Product Leadership Award, the 2001 National Tibbetts Award, the Industry Week 1997 Innovation and Technology Award, the 1998 Discover Magazine Award, the American Ceramic Society's Henry Award (1995), the Xerox Materials Research Award (1986 & 1991), and several outstanding paper awards.

He is a member of the Tissue Engineering Society International, Materials Research Society, IEEE, Golden Key National Honor Society, and Sigma Xi. He has organized or co-organized five international conferences (MRS, EMRS (Europe), SSDM (Japan) and IEEE SISC). He is also on the board of directors for VaxDesign Corporation, Sciperio Inc., nScrypt Inc., BioFlorida, the Pittsburgh Tissue Engineering Initiative, and the Scientific Advisory Board of the National Tissue Engineering Center.

Vaccine Production: Potential Engineering Approaches to a Pandemic
April 10-11, 2006

If you can read this message you probably are using a browser that is out dated.
Your internet browsing experience will improve by simply upgrading your browser
to the current version.